reason report
bottom line reiter contrarian view strong
structur buy hold hospit name higher pt
see weak solid print buy opportun
maintain ebitda see upsid estim believ
consensu conserv better expect ss revenu
 hospit price growth potenti ebitda margin expans
remaind acquir asset integr
core busi store ss adj admiss growth ex uk
low end guidanc even season weaker
quarter expect continu strength even difficult comp
time even see potenti normal growth guidanc
exceed current rang potenti hospit
price growth remain structur elev level acuiti
servic line improv impress capac util
ambulatori asset base network access point grow
meaning under-valued estim sotp
valuat rang cf gener remain solid
capit deploy capital-expenditure benefit increment
mm tax reform tailwind drive ambulatori
expans inpati bed add
line revenu ebitda report net revenu
compar consensu adjust ebitda mm
vs consensu mm ep beat consensu exhibit
ss adj admiss growth ex uk low end
guidanc even season weaker quarter expect
continu strength even difficult comp ex uk ss inpati
admin bp better ss birth posit first
time two year exhibit
price solid driven improv acuiti servic line
growth potenti remain structur elev level
commerci adjust admiss increas sinc
ss medicar adj admiss increas
ss medicaid admiss flat self pay increas
believ may due state delay medicaid
oper expens line across board ss swb
bp yoy labor cost remain stabl ss opex flat yoy
ev/ebitda
net debt total capit
price-to-earnings lt ep growth
estimate lt ep growth compound-annual-growth-rate
compani inform leerink partner llc research
revenu million bad debt ep present ex one-tim item
pleas refer page import disclosur price chart analyst certif
guidanc reiter appear conserv reiter
guidanc mm midpoint versu consensu mm
time report guidanc appear achiev hca
solid ambulatori footprint conserv hurrican impact baselin
maintain ebitda see upsid
better expect ss revenu hospit price growth
potenti ebitda margin expans remaind
acquir asset integr core busi
ebitda mm mm respect exhibit
solid capit deploy opportun tax reform lead
multipl expans opportun capit expenditur
mm includ acquisit track guidanc
could lead multipl expans larg opportun
also repurchas mm share net debt ebitda
disclos ambulatori financi estim
sotp part valuat could yield valuat
ebitda exposur higher multipl ambulatori
segment given public privat comp expect increas
access point today oper
reiter op increas pt pt contempl
ev/ebitda exhibit
reiter contrarian view strong structur buy hold hospit name
higher pt see weak solid print buy opportun
maintain ebitda see upsid estim believ consensu
conserv better expect ss revenu hospit price growth potenti
ebitda margin expans remaind acquir asset integr
core busi ss adj admiss growth ex uk low end
guidanc even season weaker quarter expect continu strength even
difficult comp time even see potenti normal growth guidanc
exceed current rang potenti hospit price growth remain
structur elev level acuiti servic line improv impress
capac util ambulatori asset base network access point grow
meaning under-valued estim sotp valuat rang
cf gener remain solid capit deploy capital-expenditure benefit
increment mm tax reform tailwind drive ambulatori expans
inpati bed add
line revenu ebitda report net revenu compar consensu
adjust ebitda mm vs consensu mm ep beat consensu
ss adj admiss growth ex uk low end guidanc even
season weaker quarter expect continu strength even difficult comp
ex uk ss inpati admin bp better ss birth posit first time
two year
holdingsleerinkconsensusqoqyoynet ebitda bpsd incom net facilityrev/adj admiss bpsadmiss bpsadj admiss bpsss inpati surgeri bpsss outpati surgeri bpser visit bpsexpensessalaries/net bpssupplies/net bpsother expenses/net bpsreport mm except per sharereport estimatesfactset consensu healthcar inc
price solid driven improv acuiti servic line growth potenti remain
structur elev level commerci adjust admiss increas sinc
ss medicar adj admiss increas ss medicaid admiss
flat self-pay increas believ may due state delay
compani report leerink partner llc estim note ss commerci adjust admiss exclud impact exchang
oper expens line across board ss swb bp yoy labor cost
remain stabl ss opex flat yoy
guidanc reiter appear conserv reiter guidanc mm
midpoint versu consensu mm time report guidanc appear
achiev hca solid ambulatori footprint conserv hurrican impact
maintain ebitda see upsid better expect ss
revenu hospit price growth potenti ebitda margin expans
remaind acquir asset integr core busi
ebitda mm mm respect
compani report leerink partner llc research estim note mm except bp
consensusleerinkconsensusleerinkconsensusleerinkconsensusleerinkconsensusleerinkrevenu expense/net opex/net rev/ per adj admiss adj admin adjust ss top line growth bp improv bad debt normal baselin ex-hurrican mm ramp acquir asset unannounc bp improvementintern uk operationsok leerink ebitda inc
solid capit deploy opportun tax reform lead multipl expans
 opportun capit expenditur mm includ acquisit track
guidanc could lead multipl expans larg opportun also
repurchas mm share net debt ebitda
disclos ambulatori financi estim sum-of-the-part
sotp valuat could yield valuat ebitda exposur
higher multipl ambulatori segment given public privat comp expect
increas access point today oper
disclos ambulatori financi estim sotp part valuat
could yield valuat ebitda exposur higher multipl
ambulatori segment given public privat comp
reiter op increas pt pt contempl ev/ebitda
pt contempl ev/ebitda ebitda view
factset compani report leerink partner llc research estim note mm except per share
trade consensu ev/ebitda
factset compani report leerink partner llc research estim note mm except per share
primari valuat methodolog base rel ev/ebitda rel
ev/ebitda track function compani histori hospit group averag
assess potenti ev/ebitda expans next month base forward
forecast contempl underli fundament implic healthcar reform
base rate outperform price target base
ev/ebitda ebitda view
downsid risk valuat includ
possibl delay medicaid expans current non-expans state
downsid risk leverag
legisl regul cut govern commerci payer reimburs
pressur shift outpati ambulatori set
incom statement mm except provis doubt net expensessalari oper total oper depreci incom ebit net interest pbt incom tax incom yoy incom attribut non-controlling net incom attribut net incom attribut share dilut yoy dilut yoy growth growth expense/net opex/net debt/gross inc
price target base pro forma ebitda leverag post transact
debt repay
downsid risk valuat includ
possibl delay medicaid expans current non-expans state
delay time sale hospit asset initi improv physician
product expens reduct
exposur larg earn swing result high leverag
variou on-going legal proceed may result cash outflow
primari valuat methodolog base rel ev/ebitda
rel ev/ebitda track function compani histori
hospit group averag assess potenti ev/ebitda expans
next month base forward forecast contempl underli
fundament implic healthcar reform
base rate outperform price target
base ev/ebitda ebitda view
downsid risk valuat includ
possibl delay medicaid expans current non-expans state
downsid risk leverag
legisl regul cut govern commerci payer reimburs
pressur shift outpati ambulatori set
primari valuat methodolog base rel ev/ebitda rel
ev/ebitda track function compani histori hospit group averag
assess potenti ev/ebitda expans next month base forward
forecast contempl underli fundament implic healthcar reform
dcf valuat leverag forward forecast wacc termin growth rate
point potenti multipl expans along sector compani specif
catalyst expect greater potenti multipl expans dcf valuat point
significantli upsid peer current trade level base rate
lpnt market perform price target base ev/ebitda
downsid risk valuat includ
possibl delay medicaid expans current non-expans state
downsid risk leverag
legisl regul cut government commerci payer reimburs
margin expans headwind class
lack
rate outperform price target base combin enterpris
valu ebitda multipl valuat base forward forecast contempl underli
fundament implic sum-of-the-part valuat rang shown exhibit
may note
downsid risk valuat includ
possibl delay medicaid expans current non-expans state
downsid risk leverag
legisl regul cut government commerci payer reimburs
primari valuat methodolog base rel ev/ebitda rel
ev/ebitda track function compani histori hospit group averag
assess potenti ev/ebitda expans next month base forward
forecast contempl underli fundament implic healthcar reform
dcf valuat leverag forward forecast wacc termin growth rate
point potenti multipl expans along sector compani specif
catalyst expect greater potenti multipl expans dcf valuat point
significantli upsid peer current trade level base rate
outperform price target base ev/ebitda
downsid risk valuat includ
possibl delay medicaid expans current non-expans state
acut care segment highli concentr la vega texa
cut govern commerci payer reimburs
declin receiv collect rate
pay mix pressur behavior segment
